What is Idexx Laboratories's americas — total consolidated revenue?

Idexx Laboratories (IDXX) reported americas — total consolidated revenue of $752.63M in Q4 2025.

How has Idexx Laboratories's americas — total consolidated revenue changed year-over-year?

Idexx Laboratories's americas — total consolidated revenue increased by 8.7% year-over-year, from $692.44M to $752.63M.

What is the long-term trend for Idexx Laboratories's americas — total consolidated revenue?

Over 4 years (2021 to 2025), Idexx Laboratories's americas — total consolidated revenue has grown at a 8.1% compound annual growth rate (CAGR), from $2.20B to $3.01B.

What does americas — total consolidated revenue mean?

The total amount of money earned from sales in the Americas region.

Geographic · Total consolidated revenue

Americas — Total consolidated revenue

Idexx Laboratories Americas — Total consolidated revenue remained flat by 0.0% to $752.63M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.7%, from $692.44M to $752.63M. Over 4 years (FY 2021 to FY 2025), Americas — Total consolidated revenue shows an upward trend with a 8.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityStable

First reportedQ1 2016

Last reportedQ4 2025

Rolls up toTotal Revenue

How to read this metric

An increase indicates growing market share or higher demand for diagnostic services in the region, while a decrease may signal increased competition or economic headwinds affecting veterinary spending.

Detailed definition

This metric represents the total gross income generated from the sale of diagnostic products, equipment, and veterinary...

Peer comparison

Comparable to regional revenue reporting for other global healthcare or life sciences companies, typically benchmarked against regional GDP growth and veterinary industry spending trends.

Metric ID: idxx_segment_americas_total_consolidated_revenue

Historical Data

5 years

	FY'21	FY'22	FY'23	FY'24	FY'25
Value	$2.20B	$2.40B	$2.63B	$2.77B	$3.01B
YoY Change	—	+9.0%	+9.4%	+5.5%	+8.7%

Range$2.20B – $3.01B

CAGR+8.1%

Avg YoY Growth+8.1%

Median YoY Growth+8.9%

Current Streak4+ years growth

Similar Metrics at Other Companies

International Business MachinesIBM View metric

Equinix, Inc.EQIX View metric

CDN

CDNCDN View metric

Keysight TechnologiesKEYS View metric

MSCIMSCI View metric

Teradyne, Inc.TER View metric

Frequently Asked Questions

What is Idexx Laboratories's americas — total consolidated revenue?: Idexx Laboratories (IDXX) reported americas — total consolidated revenue of $752.63M in Q4 2025.
How has Idexx Laboratories's americas — total consolidated revenue changed year-over-year?: Idexx Laboratories's americas — total consolidated revenue increased by 8.7% year-over-year, from $692.44M to $752.63M.
What is the long-term trend for Idexx Laboratories's americas — total consolidated revenue?: Over 4 years (2021 to 2025), Idexx Laboratories's americas — total consolidated revenue has grown at a 8.1% compound annual growth rate (CAGR), from $2.20B to $3.01B.
What does americas — total consolidated revenue mean?: The total amount of money earned from sales in the Americas region.